Brief: Ovid Therapeutics Reports Business Update, Fourth Quarter And Full Year 2021 Financial Results

Ovid Therapeutics

15/03/2022 12:13

March 15 (Reuters) - Ovid Therapeutics Inc  OVID.O :
    * OVID THERAPEUTICS REPORTS BUSINESS UPDATE, FOURTH QUARTER
AND
FULL YEAR 2021 FINANCIAL RESULTS
    * Q4 LOSS PER SHARE $0.38
    * CASH AND CASH EQUIVALENTS AS OF DECEMBER 31, 2021 WAS
$187.8
MILLION
    * ON TRACK TO INITIATE A CLINICAL TRIAL THIS YEAR FOR OV329
    * Q4 EARNINGS PER SHARE VIEW $-0.16 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX5klLFY 
Further company coverage:  OVID.O 

 ((Reuters.Briefs@thomsonreuters.com;))